ID   NP-01
AC   CVCL_C7NE
SY   Clone 1; anti-NPTXR mAb-1
DR   Wikidata; Q117704726
RX   Patent=US20210040208;
RX   PubMed=32847597;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-02856.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95502; Human NPTXR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
RX   Patent=US20210040208;
RA   Kanda M.;
RT   "Therapeutic agent targeted to receptor protein, test agent, antibody
RT   that binds to receptor protein, and screening method for molecularly
RT   targeted drugs.";
RL   Patent number US20210040208, 11-Feb-2021.
//
RX   PubMed=32847597; DOI=10.1186/s12943-020-01251-0;
RA   Kanda M., Shimizu D., Sawaki K., Nakamura S., Umeda S., Miwa T.,
RA   Tanaka H., Tanaka C., Hayashi M., Iguchi Y., Yamada S., Katsuno M.,
RA   Kodera Y.;
RT   "Therapeutic monoclonal antibody targeting of neuronal pentraxin
RT   receptor to control metastasis in gastric cancer.";
RL   Mol. Cancer 19:131.1-131.14(2020).
//